Compare Nuwellis Inc (NUWE) vs Trip.com Group Ltd (TCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Trip.com Group Ltd — how do they compare? Nuwellis Inc trades at $0.8 (market cap $2.50M), while Trip.com Group Ltd trades at $39.39 (market cap $26.04B). The key difference: Trip.com Group Ltd is far larger — about 10416× Nuwellis Inc's market cap, and Trip.com Group Ltd pays a 0.42% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | TCOM | |
|---|---|---|
Market Cap | $2.50M | $26.04B |
Sector | Technology | Consumer Cyclical |
52-Week High | $164.50 | $78.96 |
52-Week Low | $0.73 | $39.19 |
Enterprise Value | -$1.21M | $18.64B |
Dividend Yield | — | 0.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
Trip.com (TCOM) trades at $40.50, down 1.29% with bearish technical signals despite strong fundamentals. The company reported robust 2025 results with $62.41B revenue and 53.34% net margin, though recent quarters show earnings misses. Valuation metrics appear attractive with P/E of 6.01 and EV/EBITDA of 3.21. However, the stock faces headwinds from a recent $770M Chinese antitrust penalty and declining cash flow trends.
The investment case balances deep value against regulatory risks. Analyst consensus remains bullish with $59.29 price target (47% upside), but technical weakness and China regulatory overhang create near-term uncertainty. Long-term growth prospects in travel recovery support the bull case, though investors should monitor Q2 2026 earnings due September 15 for confirmation of business momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Trip.com Group Ltd
Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 78% of sales from accommodation reservations and transportation ticketing in 2020. The rest of revenue comes from package tours and corporate travel. Prior to the pandemic in 2019, the company generated 25% of revenue from international business, which is important to its margin expansion. Most of sales come from websites and mobile platforms, while the rest come from call centers. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Toncheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.
Read more on TCOM →
